Big tech says AI can find a cure for cancer. So where is it?

Artificial intelligence is frequently touted as a potential cure-all for cancer, but achieving a definitive solution remains elusive. One individual who experienced the devastating effects of cancer was June, a grandmother the reporter recalls vividly. June's cancer had spread to her pancreas, and her prognosis was grim, with a low likelihood of survival. Cancer is a common and deadly disease, affecting millions worldwide and posing significant challenges for treatment and care.

While AI's potential applications in cancer research have shown promise, experts caution against overselling its capabilities. Medical oncologist Sherene Loi, for instance, believes that AI can improve aspects of cancer care, such as early detection and personalized treatment plans. However, she emphasizes that a single cure for all forms of cancer is improbable due to the disease's complexity and variability.

AI's role in cancer management is primarily focused on enhancing medical imaging analysis, drug discovery, and treatment planning. Machine-learning algorithms can detect subtle changes in medical images, potentially identifying cancerous cells before clinical diagnosis. This could lead to more effective interventions and early-stage treatment, ultimately improving patient outcomes.

Despite these advancements, the complexities of cancer biology and the need for tailored therapies mean that AI alone cannot solve the disease. A multidisciplinary approach combining AI with traditional research methods is likely to yield the most significant progress in cancer treatment.